Wogonin is shown to suppress MM-stimulated angiogenesis and reduce levels of secreted VEGF, platelet-derived growth factor (PDGF), and bFGF by way of the c-Myc/HIF-1α/VEGF pathway [38]. Here, FGF2 is linked to Miyoshi myopathy.